National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

nelarabinePatient Information
An arabinonucleoside antimetabolite with antineoplastic activity. Nelarabine is demethoxylated by adenosine deaminase to become biologically active 9-beta-D-arabinosylguanine (ara-G); ara-G incorporates into DNA, thereby inhibiting DNA synthesis and inducing an S phase-dependent apoptosis of tumor cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Arranon
Code names:506U78
GW506U78
Chemical structure names:
  • 2-amino-6-methoxypurine arabinoside
  • 2-amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine



Previous:natural human interferon alpha OPC-18, Navelbine, NB1011, Nebcin, nedaplatin
Next:nelfinavir mesylate, Neo-Oestronol I, Neogest, Neoquin, Neoral

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov